Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Heart Rhythm Clinical and Research Solutions, LLC
- Study ID
- NCT06436924
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Left Atrial Appendage Device Implant — DEVICEThe Watchman Device is implanted into the left atrial appendage and is designed to close it off and keep blood clots from escaping that area.
Study Details
SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.
Key Dates
- Start date
- May 14, 2024
- Status verified
- Oct 2025
- Primary completion
- Dec 30, 2025
- Completion
- Mar 30, 2026
Study Design
- Enrollment
- 678 participants (estimated)
Arms
- Arm: Subjects undergoing LAAO device implantWatchman LAAO device implant
Primary Outcome Measure
Peri-procedural complications [ Time Frame: Procedure through discharge, an average of 1-3 days ]
Central Contacts
- Jennifer Moss615-448-5770
- Carolyn Mills205-807-0864
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Grandview Medical Center | Birmingham | Alabama | 35243 | Anil Rajendra, MD (PRINCIPAL_INVESTIGATOR) |
| Pima Heart and Vascular | Tucson | Arizona | 85704 | Monica Varela 520-838-3540 Aleksander Herber Thomas Waggoner, MD (PRINCIPAL_INVESTIGATOR) |
| The Medical Center of Aurora | Aurora | Colorado | 80012 | Chris Dutka, Research Coordinator Christopher Porterfield, MD (PRINCIPAL_INVESTIGATOR) |
| Ascension St. Vincent | Jacksonville | Florida | 32204 | Anthony Magnano, MD (PRINCIPAL_INVESTIGATOR) |
| Naples Community Hospital | Naples | Florida | 34102 | Kathy Byrd 239-624-4200 Dinesh Sharma, M.D. (PRINCIPAL_INVESTIGATOR) |
| Memorial Health University Medical Center | Savannah | Georgia | 31404 | Todd Senn, MD (PRINCIPAL_INVESTIGATOR) David Newton, MD (SUB_INVESTIGATOR) |
| Medical University of South Carolina | Columbia | South Carolina | 29204 | Jacqueline Sheriod-Scott 803-409-7175 Barbara Burrell Loren Morgan, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By condition
By specialty
Related Studies
- Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot StudyPHASE2 · Recruiting · University of South Florida · Tampa, Florida
- CardioFocus HeartLight Post-Approval StudyRecruiting · CardioFocus · Tucson, Arizona
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas